Journal of Tongji University(Medical Science), Volume. 46, Issue 3, 470(2025)
Combined antimicrobial activity of D-phenyllactic acid and hydroxypropyl-β-cyclodextrin against Fusobacterium nucleatum and its molecular mechanisms
ObjectiveTo develop more efficient approaches for inhibiting the growth of Fusobacterium nucleatum (F. nucleatum).MethodsThe effects of inhibiting Fusobacterium nucleatum of D-phenyllactic acid (D-PLA) and hydroxypropyl-β-cyclodextrin (HP-β-CD) were explored by the concentration gradient method, the effect of D-PLA combined with HP-β-CD on inhibiting the growth of Fusobacterium nucleatum was explored by the checkerboard method, and the molecular structure mechanism underlying drug combination effects was analyzed. During the experimental process, the spectrophotometry was used to test the growth of F. nucleatum within 48 hours, and then the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were determined by integrating the growth curve and the plate inoculation results to evaluate the antibacterial effect. The conjugation molecular structure model was constructed by the quantum chemical QM calculations combined with energy data.ResultsD-PLA had inhibitory effect on the growth of F. nucleatum, the MIC was 0.6 mg/mL while MBC was 4.5 mg/mL. The MIC of HP-β-CD was 1.0 mg/mL against Fusobacterium nucleatum.ConclusionThe combination of D-PLA and HP-β-CD shows a fractional inhibitory concentration (FIC) index of 0.25 (<0.5), forms an envelope structure at the molecular level, and exhibits synergistic antibacterial effects against Fusobacterium nucleatum.
Get Citation
Copy Citation Text
YAN Xiaoli, ZHAN Duanhong, SHENG Linfeng, HUANG Xiawei, DU Chenshuo, HU Zihao. Combined antimicrobial activity of D-phenyllactic acid and hydroxypropyl-β-cyclodextrin against Fusobacterium nucleatum and its molecular mechanisms[J]. Journal of Tongji University(Medical Science), 2025, 46(3): 470
Category:
Received: Sep. 28, 2024
Accepted: Aug. 26, 2025
Published Online: Aug. 26, 2025
The Author Email: